Ad-free. Influence-free. Powered by consumers.
Skip to Main ContentThe payment for your account couldn't be processed or you've canceled your account with us.
Re-activateRosuvastatin (Crestor) reduced the risk of a potentially fatal blood-clot disorder called venous thromboembolism in a new study, The New York Times reports today. The study, published in the New England Journal of Medicine and funded by Astra Zeneca, suggests that the cholesterol-lowering statin Crestor, already used to prevent heart attack and stroke, may have an additional benefit in protecting people against clotting.
Given this news, you may be considering switching your cholesterol-lowering prescription to Crestor. Not so fast. We've previously reported that this powerful statin is not for everyone with high cholesterol. And it's costly—at about $105 for a month's supply, a year's worth of Crestor can exceed $1,000. As our Best Buy Drugs report on statins discusses, most people who need a statin should take the lowest dose that reduces their "bad" LDL cholesterol to an acceptable "target" level. High doses of statins pose greater risk—of muscle and liver problems. Lovastatin (Mevacor and generic) and simvastatin (Zocor and generic) lower LDL and are much cheaper (a month's supply of generic simvastatin costs around $30 at many retail pharmacies or even as low as $6 at Costco).
—Ginger Skinner
Read our new report on high cholesterol, and talk to your doctor about the best treatment for you. For more on anti-clotting drugs, see our free Best Buy Drugs report.
Build & Buy Car Buying Service
Save thousands off MSRP with upfront dealer pricing information and a transparent car buying experience.
Get Ratings on the go and compare
while you shop
